Shares of Mankind Pharma debut with over 20 percent premium
The company commanded a market valuation of Rs 54,816.52 crore.
New Delhi: Shares of Mankind Pharma made a remarkable debut on the stock exchanges on Tuesday, listing with a premium of over 20 per cent against the issue price of Rs 1,080.The stock began the trade at Rs 1,300, up 20.37 per cent on the BSE. It further zoomed 24.53 per cent to Rs 1,366.At the NSE, shares of the company made its debut at Rs 1,300.The company commanded a market valuation of...
New Delhi: Shares of Mankind Pharma made a remarkable debut on the stock exchanges on Tuesday, listing with a premium of over 20 per cent against the issue price of Rs 1,080.
At the NSE, shares of the company made its debut at Rs 1,300.
The company commanded a market valuation of Rs 54,816.52 crore.
The initial share sale of Mankind Pharma received 15.32 times subscription last month.
The company's IPO was entirely an Offer for Sale (OFS) of 4,00,58,844 equity shares by promoters and other existing shareholders.
Price range for the offer was at Rs 1,026-1,080 a share.
Read also: Mankind Pharma invests in Actimed Therapeutics for cancer cachexia treatment
Read also: Mankind Pharma sets IPO price band of Rs 1,026 to Rs 1,080 per share
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd